Patient-Reported Outcome Measurement Information System (PROMIS)

Jan 4, 2021 | Conduits News

PROMIS (Patient-Reported Outcome Measurement Information System) is a joint ConduITS Clinical & Translational Science Award and The Office of Chief Research Informatics Officer (CRIO) program which provides dynamic tools to measure health outcomes from the patient perspective. These tools are comprised of highly reliable, precise measures of patient-reported health status for physical, mental, and social well-being. This resource can be used to measure health symptoms and health-related quality of life domains such as pain, fatigue, depression, and physical function, which are relevant to a variety of clinical trials supported at Mount Sinai.

Clinical measures of health outcomes may have little relevance to the day-to-day functioning of patients with chronic diseases. Often, the best way patients can judge the effectiveness of treatments is by changes in their symptoms. This feedback or data is called Patient Reported Outcomes. The Patient Reported Outcome Measurement Information System (PROMIS) is a system built on something called item response theory.

PROMIS was established in 2004 as a NIH-funded initiative to develop and validate patient reported outcomes for clinical research and practice. It developed into a cooperative network that has had a substantial impact, with approximately 70 domains measuring pain, fatigue, depression, anxiety, sleep disturbance, physical function, social function, and sexual function, among other areas, available for use today. Measures were developed for children and adults, and has been translated into >40 languages (including English and Spanish). The work surrounding PROMIS has resulted in over 400 publications. More than 100 NIH grants have supported investigations using PROMIS instruments. PROMIS is available in a variety of forms, including paper and pencil, web and mobile platforms, as well as via electronic health record (EHR) data capture.

An example of what forms Mount Sinai is currently able to implement can be found at this link:

https://researchroadmap.mssm.edu/wp-content/uploads/2020/12/PROMIS-surveys.pdf

Link to the website that expands upon this overview can be found at:

https://www.healthmeasures.net/explore-measurement-systems/promis

ConduITS is supported by NCATS of the NIH’s CTSA Program. Any use of CTSA-supported resources requires citation of grant number UL1TR001433 awarded to ISMMS in the acknowledgment section of every publication resulting from this support. Adherence to the NIH Public Access Policy is also required.

 

Recent ConduITS News

What does the Innovation Core do?

Mount Sinai’s Innovation Core is designed to fill the gap in the training and expertise needed to move a discovery from the research setting into a commercially viable product, or to recognize the potential for commercialization. i3 Prism i3 Prism is an early-stage...

read more

What is the Innovation Core?

Mount Sinai’s Innovation Partners (MSIP) is the technology commercialization arm of the Mount Sinai Health System, responsible for driving the real-world application of Mount Sinai discoveries and inventions, and the development of research partnerships with industry....

read more

Newsletter Special Edition

Click here to view the special edition of the Conduit Newsletter, designed in CANVA! As part of a new initiative by The Mount Sinai ConduITS Institutes for Translational Sciences (CTSA), we are thrilled to introduce our latest newsletter designed to aid researchers in...

read more

Trainee Corner

Mount Sinai CTSA Featured Trainees

Megan Januska

Megan Januska

Megan Januska, MD is an Assistant Professor in the Division of Pediatric Pulmonology in the Jack and Lucy Clark Department of Pediatrics and in the Department of Genetics and Genomic Sciences at the Icahn School of Medicine at Mount Sinai and Mount Sinai Kravis...

read more
Sangeetha Vadakke-Madathil

Sangeetha Vadakke-Madathil

Sangeetha Vadakke-Madathil, PhD, is currently a junior faculty (Instructor of Medicine) at Icahn School of Medicine at Mount Sinai, New York, NY. After receiving her Ph.D. degree in human hematopoietic stem cells and transplant biology from National Centre for Cell...

read more